Stay updated on Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page
- Check6 days agoChange DetectedRemoved Melanoma and the related topic MedlinePlus Genetics from the page's related topics.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedMelanoma is added as a topic and MedlinePlus Genetics is listed as related topics. The page revision updated from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check42 days agoChange DetectedMinor revision update from v3.4.0 to v3.4.1; no changes to study content, data, or page functionality are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded a glossary toggle and new metadata fields (Last Update Submitted that Met QC Criteria, No FEAR Act Data) with Revision: v3.4.0. Removed older/duplicate metadata terms (Last Update Submitted that met QC Criteria, No FEAR Act data) and related references (e.g., MedlinePlus Genetics).SummaryDifference0.3%

- Check64 days agoChange DetectedRemoved related topics Melanoma and MedlinePlus Genetics, and added Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page.